Fosamax has also been prescribed to increase bone mass
in men with osteoporosis. Brand name
Fosamax is manufactured
in the United States by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. In about 2008-2009, Fosamax became widely available in its generic form (alendronate sodium).
Side effects of Fosamax may include the following:
1. Esophagus problems including irritation, inflammation, or ulcers
2.